Posted in | News | Industrial Robotics

Symbotic Enhances Robotics Capabilities with Acquisition of Veo Robotics’ FreeMove Technology

Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced it has acquired substantially all of the assets of Veo Robotics, an innovator in intelligent safeguarding for industrial robots. Assets purchased under this agreement include the FreeMove® 3D depth-sensing computer vision system for industrial workcells and all related intellectual property. By integrating FreeMove into its robotic warehouse automation system, Symbotic expects to increase productivity with more dynamic, flexible human-machine collaboration.

“The innovative FreeMove vision system allows Symbotic to enhance productivity for customers and provide the highest levels of safety in environments where humans interact with robots,” said Rick Cohen, Chairman and Chief Executive Officer of Symbotic. “We are pleased to have the former Veo Robotics team join Symbotic where they will continue this exciting work as they bring their talent, expertise, and cutting-edge technology to our company.”

The FreeMove system’s patented sensors and software monitor collaborative robot workcells to dynamically anticipate the future position of humans and objects within the robot’s environment and autonomously restrict or resume motion, ensuring worker safety without sacrificing efficiency. FreeMove is the only intelligent 3D robotic safeguarding solution to meet EU standards for safety, including ISO 13849 certification for PLd, Category 3 from TUV Rheinland, which is key for Symbotic’s future growth.

The $8.7 million transaction closed on July 19, 2024.

Source:

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.